News – Johns Hopkins University Student Well-Being

Johns Hopkins responds to Supreme Court decision to overturn 'Roe v. Wade'

'Our institutions will continue to be guided by the evidence-based best practices,' university and medicine leaders write in a message to the Johns Hopkins community

U.S. rolls out COVID-19 vaccines for youngest children

The CDC and FDA approved vaccines by Moderna and Pfizer/BioNTech in children older than 6 months; vaccinations began this week

A space for reflection and celebration

A Friday, June 17 event, Juneteenth at Homewood: Expressions of Freedom, brought together Johns Hopkins and Baltimore community members for a celebratory afternoon filled with music, dance, and speeches

Flawed AI makes robots racist, sexist

New work led by several universities, including Johns Hopkins, shows that neural networks built from biased Internet data teach robots to enact toxic stereotypes

Office of Institutional Equity releases annual report for 2021

Report includes information about the types of complaints reported, timelines for investigations, and a new section focused on student data

After Roe falls

Johns Hopkins experts discuss a future without the safeguards outlined in 'Roe v. Wade'

U.S. infertility rate plateaus

A new analysis of data shows a plateau in infertility rates, but also shows disparities for women of color and for women with less access to health care, highlighting the need for continued work in public health services

Johns Hopkins to host conversation with Donna Shalala, former HHS secretary and member of Congress

Shalala, a former HHS secretary and member of Congress, will join Johns Hopkins Health System President Kevin Sowers to discuss health care trends and challenges, leadership, and service

FDA authorizes COVID-19 vaccines for children under 5 years old. What's next?

Vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks

What you need to know about the Novavax vaccine

Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19. Vaccine expert William Moss discusses its strengths and weaknesses ahead of its potential emergency use authorization.